“This document presents considerations from the perspective of the U.S. Centers for Disease Control & Prevention (CDC) for implementing the shielding approach in humanitarian settings as outlined in guidance documents focused on camps, displaced populations and low-resource settings.1,2 This approach has never been documented (other than WWII, among others) and has raised questions and concerns among humanitarian partners who support response activities in these settings.”
Only in Covidland could a newly installed executor overrule a panel of seasoned experts and physicians to recommend expanded use of a dangerous, experimental, emergency authorized gene therapy. The C.D.C.’s Advisory Committee on Immunization Practices already recommended the boosters for a wide range of Americans, including tens of millions of older adults and younger people at high risk for the disease. But that wasn’t enough for Dr. Rochelle Walensky, C.D.C. director since January 20 2021, who moved to align the bureau’s official protocol with that of the FDA.